ALK and cancer: To validate the role of GSTP1 in CSC maintenance by a more clinically relevant model and explore whether GSTP1 could serve as a therapeutic target in LUAD treatment, we established cancer organoids from a resected primary LUAD with ALK translocation (LUAD‐OG1) as model tissues for further in vitro and in vivo studies.